Adobe
ADBE
Lennar Corp
LEN
Petroleo Brasileiro SA Petrobras
PBR
Apple
AAPL
D.R. Horton
DHI
US Stock MarketDetailed Quotes
TNXP Tonix Pharmaceuticals
- 0.3700
- -0.0153-3.97%
Close Dec 26 16:00 ET
- 0.3645
- -0.0055-1.49%
Post 16:24 ET
69.15MMarket Cap0.00P/E (TTM)
0.3919High0.3500Low75.26MVolume0.3848Open0.3853Pre Close27.80MTurnover40.27%Turnover Ratio0.00P/E (Static)186.89MShares14.080052wk High0.93P/B69.15MFloat Cap0.118052wk Low--Dividend TTM186.89MShs Float263679868.1600Historical High--Div YieldTTM10.88%Amplitude0.1180Historical Low0.3690Avg Price1Lot Size
About Tonix Pharmaceuticals Company
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering. Its portfolio includes TNX-102 SL, TNX-601, TNX-801, and TNX-1800. The company was founded by Seth Lederman and Donald W. Landry on November 16, 2007 and is headquartered in Chatham, NJ.
Company Profile
SymbolTNXP
Company NameTonix Pharmaceuticals
Listing DateAug 9, 2013
Founded2007
CEODr. Seth Lederman, M.D.
MarketNASDAQ
Employees103
Fiscal Year Ends12-31
Address26 Main Street,Suite 101
CityChatham
ProvinceNew Jersey
CountryUnited States of America
Zip Code07928
Phone1-862-799-8599
Websitehttp://www.tonixpharma.com
Company Executives
- Name
- Position
- Salary
- Dr. Seth Lederman, M.D.
- Chairman of the Board, President and Chief Executive Officer
- 2.05M
- Bradley Saenger, C.P.A.
- Chief Financial Officer, Principal Accounting Officer and Treasurer
- 904.91K
- Jessica Edgar Morris
- Chief Operating Officer
- 928.60K
- Dr. Gregory M. Sullivan, M.D.
- Chief Medical Officer and Secretary
- 952.00K
- Richard H. Bagger
- Independent Director
- 82.48K
- Richard Newcomb Stillwell
- Independent Director
- 113.05K
- General David L. Grange
- Independent Director
- 82.48K
- Carolyn E. Taylor
- Independent Director
- 82.48K
- Margaret Smith Bell
- Independent Director
- 82.48K
- Dr. Adeoye Y. Olukotun, M.D.
- Independent Director
- 82.48K
- James Treco
- Lead Independent Director
- 102.48K
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
